vs
Side-by-side financial comparison of LandBridge Co LLC (LB) and SBC Medical Group Holdings Inc (SBC). Click either name above to swap in a different company.
LandBridge Co LLC is the larger business by last-quarter revenue ($56.8M vs $39.6M, roughly 1.4× SBC Medical Group Holdings Inc). SBC Medical Group Holdings Inc runs the higher net margin — 35.9% vs 14.2%, a 21.7% gap on every dollar of revenue. On growth, LandBridge Co LLC posted the faster year-over-year revenue change (55.6% vs -10.9%). LandBridge Co LLC produced more free cash flow last quarter ($122.0M vs $51.2M). Over the past eight quarters, LandBridge Co LLC's revenue compounded faster (72.8% CAGR vs -15.0%).
SBC Medical Group Holdings Inc. is a leading Japan-headquartered healthcare provider primarily focused on aesthetic medicine, dermatology, and anti-aging wellness services. It operates an extensive network of clinics across Japan, catering to both domestic patients and international medical tourists, with core offerings including cosmetic surgery and non-invasive skincare treatments.
LB vs SBC — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $56.8M | $39.6M |
| Net Profit | $8.1M | $14.2M |
| Gross Margin | — | 73.1% |
| Operating Margin | 60.0% | 32.5% |
| Net Margin | 14.2% | 35.9% |
| Revenue YoY | 55.6% | -10.9% |
| Net Profit YoY | -83.7% | 117.2% |
| EPS (diluted) | $0.24 | $0.15 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $56.8M | $39.6M | ||
| Q3 25 | $50.8M | $43.4M | ||
| Q2 25 | $47.5M | $43.4M | ||
| Q1 25 | $44.0M | $47.3M | ||
| Q4 24 | $36.5M | $44.4M | ||
| Q3 24 | $28.5M | $53.1M | ||
| Q2 24 | $26.0M | $53.1M | ||
| Q1 24 | $19.0M | $54.8M |
| Q4 25 | $8.1M | $14.2M | ||
| Q3 25 | $8.1M | $12.8M | ||
| Q2 25 | $7.5M | $2.5M | ||
| Q1 25 | $6.5M | $21.5M | ||
| Q4 24 | $49.3M | $6.5M | ||
| Q3 24 | $2.7M | $2.8M | ||
| Q2 24 | $-57.7M | $18.5M | ||
| Q1 24 | $10.8M | $18.8M |
| Q4 25 | — | 73.1% | ||
| Q3 25 | — | 70.6% | ||
| Q2 25 | — | 69.2% | ||
| Q1 25 | — | 79.7% | ||
| Q4 24 | — | 76.3% | ||
| Q3 24 | — | 81.5% | ||
| Q2 24 | — | 74.2% | ||
| Q1 24 | — | 72.1% |
| Q4 25 | 60.0% | 32.5% | ||
| Q3 25 | 60.8% | 36.6% | ||
| Q2 25 | 60.0% | 33.6% | ||
| Q1 25 | 57.0% | 51.1% | ||
| Q4 24 | 49.4% | 10.6% | ||
| Q3 24 | 11.2% | 26.1% | ||
| Q2 24 | -197.4% | 51.4% | ||
| Q1 24 | 71.1% | 44.6% |
| Q4 25 | 14.2% | 35.9% | ||
| Q3 25 | 15.9% | 29.6% | ||
| Q2 25 | 15.8% | 5.7% | ||
| Q1 25 | 14.7% | 45.4% | ||
| Q4 24 | 135.2% | 14.7% | ||
| Q3 24 | 9.3% | 5.3% | ||
| Q2 24 | -222.1% | 34.8% | ||
| Q1 24 | 56.7% | 34.2% |
| Q4 25 | $0.24 | $0.15 | ||
| Q3 25 | $0.26 | $0.12 | ||
| Q2 25 | $0.24 | $0.02 | ||
| Q1 25 | $0.20 | $0.21 | ||
| Q4 24 | — | $0.05 | ||
| Q3 24 | $-0.04 | $0.03 | ||
| Q2 24 | — | $0.20 | ||
| Q1 24 | — | $0.20 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $30.7M | $164.1M |
| Total DebtLower is stronger | $570.7M | $42.8M |
| Stockholders' EquityBook value | $340.3M | $248.3M |
| Total Assets | $1.4B | $380.4M |
| Debt / EquityLower = less leverage | 1.68× | 0.17× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $30.7M | $164.1M | ||
| Q3 25 | $28.3M | $127.4M | ||
| Q2 25 | $20.3M | $152.7M | ||
| Q1 25 | $14.9M | $132.1M | ||
| Q4 24 | $37.0M | $125.0M | ||
| Q3 24 | $14.4M | $137.4M | ||
| Q2 24 | $24.6M | — | ||
| Q1 24 | — | — |
| Q4 25 | $570.7M | $42.8M | ||
| Q3 25 | $366.1M | $21.1M | ||
| Q2 25 | $370.9M | $7.1M | ||
| Q1 25 | $375.5M | $6.9M | ||
| Q4 24 | $385.5M | $6.6M | ||
| Q3 24 | $242.4M | $823.2K | ||
| Q2 24 | $360.8M | — | ||
| Q1 24 | — | — |
| Q4 25 | $340.3M | $248.3M | ||
| Q3 25 | $272.0M | $248.0M | ||
| Q2 25 | $266.4M | $244.6M | ||
| Q1 25 | $217.0M | $226.4M | ||
| Q4 24 | $211.8M | $195.1M | ||
| Q3 24 | $97.2M | $205.0M | ||
| Q2 24 | $296.4M | $8.8M | ||
| Q1 24 | $162.3M | $9.0M |
| Q4 25 | $1.4B | $380.4M | ||
| Q3 25 | $1.1B | $321.4M | ||
| Q2 25 | $1.1B | $315.3M | ||
| Q1 25 | $1.0B | $284.6M | ||
| Q4 24 | $1.0B | $266.1M | ||
| Q3 24 | $689.9M | $296.5M | ||
| Q2 24 | $710.5M | $19.5M | ||
| Q1 24 | — | $19.8M |
| Q4 25 | 1.68× | 0.17× | ||
| Q3 25 | 1.35× | 0.09× | ||
| Q2 25 | 1.39× | 0.03× | ||
| Q1 25 | 1.73× | 0.03× | ||
| Q4 24 | 1.82× | 0.03× | ||
| Q3 24 | 2.49× | 0.00× | ||
| Q2 24 | 1.22× | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $126.3M | $52.0M |
| Free Cash FlowOCF − Capex | $122.0M | $51.2M |
| FCF MarginFCF / Revenue | 214.9% | 129.3% |
| Capex IntensityCapex / Revenue | 7.5% | 2.0% |
| Cash ConversionOCF / Net Profit | 15.68× | 3.66× |
| TTM Free Cash FlowTrailing 4 quarters | $207.7M | $23.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $126.3M | $52.0M | ||
| Q3 25 | $34.9M | $-20.9M | ||
| Q2 25 | $37.3M | $-8.3M | ||
| Q1 25 | $15.9M | $1.9M | ||
| Q4 24 | $67.6M | $-7.3M | ||
| Q3 24 | $7.5M | $5.0M | ||
| Q2 24 | $16.0M | $19.2M | ||
| Q1 24 | $17.2M | $3.7M |
| Q4 25 | $122.0M | $51.2M | ||
| Q3 25 | $33.7M | $-20.9M | ||
| Q2 25 | $36.1M | $-8.6M | ||
| Q1 25 | $15.8M | $1.7M | ||
| Q4 24 | $66.7M | $-7.9M | ||
| Q3 24 | $7.1M | $4.6M | ||
| Q2 24 | $15.7M | $18.3M | ||
| Q1 24 | $17.1M | $3.0M |
| Q4 25 | 214.9% | 129.3% | ||
| Q3 25 | 66.3% | -48.3% | ||
| Q2 25 | 75.9% | -19.9% | ||
| Q1 25 | 36.0% | 3.5% | ||
| Q4 24 | 182.6% | -17.8% | ||
| Q3 24 | 25.1% | 8.7% | ||
| Q2 24 | 60.4% | 34.5% | ||
| Q1 24 | 90.1% | 5.4% |
| Q4 25 | 7.5% | 2.0% | ||
| Q3 25 | 2.3% | 0.1% | ||
| Q2 25 | 2.6% | 0.7% | ||
| Q1 25 | 0.2% | 0.5% | ||
| Q4 24 | 2.7% | 1.3% | ||
| Q3 24 | 1.1% | 0.8% | ||
| Q2 24 | 1.4% | 1.6% | ||
| Q1 24 | 0.5% | 1.3% |
| Q4 25 | 15.68× | 3.66× | ||
| Q3 25 | 4.31× | -1.63× | ||
| Q2 25 | 4.98× | -3.39× | ||
| Q1 25 | 2.46× | 0.09× | ||
| Q4 24 | 1.37× | -1.12× | ||
| Q3 24 | 2.80× | 1.77× | ||
| Q2 24 | — | 1.04× | ||
| Q1 24 | 1.60× | 0.20× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
LB
Segment breakdown not available.
SBC
| Franchising | $10.3M | 26% |
| Medical Corporation Shobikai | $8.1M | 21% |
| Medical Corporation Nasukai | $7.2M | 18% |
| Management Services | $6.3M | 16% |
| Rental Services | $4.3M | 11% |
| Medical Corporation Association Furinkai | $3.0M | 8% |
| Japan Medical And Beauty Inc | $656.5K | 2% |
